Screener
Ginkgo Bioworks DNA Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesFairValueDisclosure.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's total liabilities?
- Ginkgo Bioworks (DNA) reported total liabilities of $5.69M in Q2 2026.
- How has Ginkgo Bioworks's total liabilities changed year-over-year?
- Ginkgo Bioworks's total liabilities decreased by 0.0% year-over-year, from $5.69M to $5.69M.
- What is the long-term trend for Ginkgo Bioworks's total liabilities?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's total liabilities has grown at a -51.2% compound annual growth rate (CAGR), from $205.1M to $5.69M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Ginkgo Bioworks's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude